The RENEW pilot randomized controlled trial, sponsored by Taipei Medical University, addresses the growing prevalence of behavioral and emotional disorders among children, particularly ASD, which is currently estimated at 1 in 54. The intervention employs a multidisciplinary approach integrating social and emotional learning, gamification, and faith-centered values, targeting at-risk populations. Given the rising demand for effective interventions in mental health, particularly in pediatric populations, this study positions itself within a niche market that combines educational technology and mental health support. The focus on spiritual health outcomes and the participatory approach may differentiate RENEW from existing interventions, potentially leading to a unique market position. However, the trial's success will depend on demonstrating efficacy and scalability, which could attract interest from educational institutions and mental health organizations. Competitive implications include the need to monitor similar interventions and emerging technologies in the mental health space.